The genetic basis for inherited forms of sinoatrial dysfunction and atrioventricular node dysfunction

Journal of Interventional Cardiac Electrophysiology

Volumn 43, Issue 2, 2015, Pages 121-134

  Milanesi, Raffaella ^a   Bucchi, Annalisa ^a   Baruscotti, Mirko ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Atrioventricular block; AVN; AVN dysfunction; SAN; SAN dysfunction; Sick sinus syndrome

Indexed keywords

ANKYRIN; ANKYRIN B; CALCIUM CHANNEL; CALSEQUESTRIN; CAVEOLIN 3; CELL PROTEIN; EMERIN; HYPERPOLARIZATION ACTIVATED CYCLIC NUCLEOTIDE GATED CHANNEL; HYPERPOLARIZATION ACTIVATED CYCLIC NUCLEOTIDE GATED CHANNEL 4; LAMIN; MEMBRANE PROTEIN; NESPRIN; POPEYE DOMAIN CONTAINING PROTEIN; POTASSIUM CHANNEL; PROTEIN KINASE; PROTEIN PRKAG2; SODIUM CHANNEL; SODIUM CHANNEL NAV1.5; TWIN PORE POTASSIUM CHANNEL; UNCLASSIFIED DRUG; ION CHANNEL;

ATRIOVENTRICULAR NODE DYSFUNCTION; FUNCTIONAL ANATOMY; GENE MUTATION; GENETIC ASSOCIATION; HEART ATRIOVENTRICULAR NODE; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SICK SINUS SYNDROME; SINOATRIAL DYSFUNCTION; SINUS NODE; SINUS NODE DISEASE; SODIUM CHANNEL NAV1.5 GENE; CHANNELOPATHY; GENETIC PREDISPOSITION; GENETICS; HEART ARRHYTHMIA; MUTATION; PATHOPHYSIOLOGY; PHYSIOLOGY;

ARRHYTHMIAS, CARDIAC; ATRIOVENTRICULAR NODE; CHANNELOPATHIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ION CHANNELS; MUTATION; SINOATRIAL NODE;

EID: 84933676935     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-015-9998-z     Document Type: Review

References (110)

1. Dobrzynski, H., Anderson, R. H., Atkinson, A., Borbas, Z., D'Souza, A., Fraser, J. F., et al. (2013). Structure, function and clinical relevance of the cardiac conduction system, including the atrioventricular ring and outflow tract tissues. Pharmacology and Therapeutics, 139(2), 260–288.
2. Baruscotti, M., Barbuti, A., & Bucchi, A. (2010). The cardiac pacemaker current. Journal of Molecular and Cellular Cardiology, 48(1), 55–64.
3. Beinart, R., Ruskin, J., & Milan, D. (2010). The genetics of conduction disease. Heart Failure Clinics, 6(2), 201–214.
4. Benson, D. W. (2004). Genetics of atrioventricular conduction disease in humans. The Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology, 280(2), 934–939.
5. Remme, C. A. (2013). Cardiac sodium channelopathy associated with SCN5A mutations: electrophysiological, molecular and genetic aspects. The Journal of Physiology, 591(Pt 17), 4099–4116.
6. Wolf, C. M., & Berul, C. I. (2006). Inherited conduction system abnormalities—one group of diseases, many genes. Journal of Cardiovascular Electrophysiology, 17(4), 446–455.
7. Brioschi, C., Micheloni, S., Tellez, J. O., Pisoni, G., Longhi, R., Moroni, P., et al. (2009). Distribution of the pacemaker HCN4 channel mRNA and protein in the rabbit sinoatrial node. Journal of Molecular and Cellular Cardiology, 47(2), 221–227.
8. Honjo, H., Boyett, M. R., Kodama, I., & Toyama, J. (1996). Correlation between electrical activity and the size of rabbit sino-atrial node cells. The Journal of Physiology, 496(Pt 3), 795–808.
9. DiFrancesco, D. (2010). The role of the funny current in pacemaker activity. Circulation Research, 106(3), 434–446.
10. Lakatta, E. G., & DiFrancesco, D. (2009). What keeps us ticking: a funny current, a calcium clock, or both? Journal of Molecular and Cellular Cardiology, 47(2), 157–170.
11. Munk, A. A., Adjemian, R. A., Zhao, J., Ogbaghebriel, A., & Shrier, A. (1996). Electrophysiological properties of morphologically distinct cells isolated from the rabbit atrioventricular node. The Journal of Physiology, 493(Pt 3), 801–818.
12. Benson, D. W., Wang, D. W., Dyment, M., Knilans, T. K., Fish, F. A., Strieper, M. J., et al. (2003). Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). The Journal of Clinical Investigation, 112(7), 1019–1028.
13. Mangrum, J. M., & DiMarco, J. P. (2000). The evaluation and management of bradycardia. The New England Journal of Medicine, 342(10), 703–709.
14. Baruteau, A. E., Behaghel, A., Fouchard, S., Mabo, P., Schott, J. J., Dina, C., et al. (2012). Parental electrocardiographic screening identifies a high degree of inheritance for congenital and childhood nonimmune isolated atrioventricular block. Circulation, 126(12), 1469–1477.
15. Baruscotti, M., DiFrancesco, D., & Robinson, R. B. (1996). A TTX-sensitive inward sodium current contributes to spontaneous activity in newborn rabbit sino-atrial node cells. The Journal of Physiology, 492(Pt 1), 21–30.
16. + currents in pacemaker activity in the sinoatrial node. The American Journal of Physiology, 272(6 Pt 2), H2793–2806.
17. Remme, C. A., Verkerk, A. O., Hoogaars, W. M., Aanhaanen, W. T., Scicluna, B. P., Annink, C., et al. (2009). The cardiac sodium channel displays differential distribution in the conduction system and transmural heterogeneity in the murine ventricular myocardium. Basic Research in Cardiology, 104(5), 511–522.
18. Maier, S. K., Westenbroek, R. E., Yamanushi, T. T., Dobrzynski, H., Boyett, M. R., Catterall, W. A., et al. (2003). An unexpected requirement for brain-type sodium channels for control of heart rate in the mouse sinoatrial node. Proceedings of the National Academy of Sciences of the United States of America, 100(6), 3507–3512.
19. Dobrzynski, H., Boyett, M. R., & Anderson, R. H. (2007). New insights into pacemaker activity: promoting understanding of sick sinus syndrome. Circulation, 115(14), 1921–1932.
20. Makiyama, T., Akao, M., Tsuji, K., Doi, T., Ohno, S., Takenaka, K., et al. (2005). High risk for bradyarrhythmic complications in patients with Brugada syndrome caused by SCN5A gene mutations. Journal of the American College of Cardiology, 46(11), 2100–2106.
21. Chandler, N. J., Greener, I. D., Tellez, J. O., Inada, S., Musa, H., Molenaar, P., et al. (2009). Molecular architecture of the human sinus node: insights into the function of the cardiac pacemaker. Circulation, 119(12), 1562–1575.
22. Verkerk, A. O., Wilders, R., van Borren, M. M., & Tan, H. L. (2009). Is sodium current present in human sinoatrial node cells? International Journal of Biological Sciences, 5(2), 201–204.
23. Makita, N., Sumitomo, N., Watanabe, I., & Tsutsui, H. (2007). Novel SCN5A mutation (Q55X) associated with age-dependent expression of Brugada syndrome presenting as neurally mediated syncope. Heart Rhythm, 4(4), 516–519.
24. Holst, A. G., Liang, B., Jespersen, T., Bundgaard, H., Haunso, S., Svendsen, J. H., et al. (2010). Sick sinus syndrome, progressive cardiac conduction disease, atrial flutter and ventricular tachycardia caused by a novel SCN5A mutation. Cardiology, 115(4), 311–316.
25. Bezzina, C. R., Rook, M. B., Groenewegen, W. A., Herfst, L. J., van der Wal, A. C., Lam, J., et al. (2003). Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system. Circulation Research, 92(2), 159–168.
26. Smits, J. P., Koopmann, T. T., Wilders, R., Veldkamp, M. W., Opthof, T., Bhuiyan, Z. A., et al. (2005). A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families. Journal of Molecular and Cellular Cardiology, 38(6), 969–981.
27. Makita, N., Sasaki, K., Groenewegen, W. A., Yokota, T., Yokoshiki, H., Murakami, T., et al. (2005). Congenital atrial standstill associated with coinheritance of a novel SCN5A mutation and connexin 40 polymorphisms. Heart Rhythm, 2(10), 1128–1134.
28. Gui, J., Wang, T., Jones, R. P., Trump, D., Zimmer, T., & Lei, M. (2010). Multiple loss-of-function mechanisms contribute to SCN5A-related familial sick sinus syndrome. PLoS One, 5(6), e10985.
29. Olson, T. M., Michels, V. V., Ballew, J. D., Reyna, S. P., Karst, M. L., Herron, K. J., et al. (2005). Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA, 293(4), 447–454.
30. Wang, D. W., Viswanathan, P. C., Balser, J. R., George, A. L., Jr., & Benson, D. W. (2002). Clinical, genetic, and biophysical characterization of SCN5A mutations associated with atrioventricular conduction block. Circulation, 105(3), 341–346.
31. Detta, N., Frisso, G., Limongelli, G., Marzullo, M., Calabro, R., & Salvatore, F. (2014). Genetic analysis in a family affected by sick sinus syndrome may reduce the sudden death risk in a young aspiring competitive athlete. International Journal of Cardiology, 170(3), e63–65.
32. Rossenbacker, T., Carroll, S. J., Liu, H., Kuiperi, C., de Ravel, T. J., Devriendt, K., et al. (2004). Novel pore mutation in SCN5A manifests as a spectrum of phenotypes ranging from atrial flutter, conduction disease, and Brugada syndrome to sudden cardiac death. Heart Rhythm, 1(5), 610–615.
33. Horne, A. J., Eldstrom, J., Sanatani, S., & Fedida, D. (2011). A novel mechanism for LQT3 with 2:1 block: a pore-lining mutation in Nav1.5 significantly affects voltage-dependence of activation. Heart Rhythm, 8(5), 770–777.
34. Viswanathan, P. C., Benson, D. W., & Balser, J. R. (2003). A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation. The Journal of Clinical Investigation, 111(3), 341–346.
35. Tan, H. L., Bink-Boelkens, M. T., Bezzina, C. R., Viswanathan, P. C., Beaufort-Krol, G. C., van Tintelen, P. J., et al. (2001). A sodium-channel mutation causes isolated cardiac conduction disease. Nature, 409(6823), 1043–1047.
36. + channel. Acta Physiologica (Oxford, England), 194(4), 311–323.
37. Ge, J., Sun, A., Paajanen, V., Wang, S., Su, C., Yang, Z., et al. (2008). Molecular and clinical characterization of a novel SCN5A mutation associated with atrioventricular block and dilated cardiomyopathy. Circulation. Arrhythmia and Electrophysiology, 1(2), 83–92.
38. Kyndt, F., Probst, V., Potet, F., Demolombe, S., Chevallier, J. C., Baro, I., et al. (2001). Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family. Circulation, 104(25), 3081–3086.
39. Niu, D. M., Hwang, B., Hwang, H. W., Wang, N. H., Wu, J. Y., Lee, P. C., et al. (2006). A common SCN5A polymorphism attenuates a severe cardiac phenotype caused by a nonsense SCN5A mutation in a Chinese family with an inherited cardiac conduction defect. Journal of Medical Genetics, 43(10), 817–821.
40. Zumhagen, S., Veldkamp, M. W., Stallmeyer, B., Baartscheer, A., Eckardt, L., Paul, M., et al. (2013). A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome. PLoS One, 8(6), e67963.
41. Grant, A. O., Carboni, M. P., Neplioueva, V., Starmer, C. F., Memmi, M., Napolitano, C., et al. (2002). Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation. The Journal of Clinical Investigation, 110(8), 1201–1209.
42. Bennett, P. B., Yazawa, K., Makita, N., & George, A. L., Jr. (1995). Molecular mechanism for an inherited cardiac arrhythmia. Nature, 376(6542), 683–685.
43. Keller, D. I., Acharfi, S., Delacretaz, E., Benammar, N., Rotter, M., Pfammatter, J. P., et al. (2003). A novel mutation in SCN5A, delQKP 1507–1509, causing long QT syndrome: role of Q1507 residue in sodium channel inactivation. Journal of Molecular and Cellular Cardiology, 35(12), 1513–1521.
44. Akai, J., Makita, N., Sakurada, H., Shirai, N., Ueda, K., Kitabatake, A., et al. (2000). A novel SCN5A mutation associated with idiopathic ventricular fibrillation without typical ECG findings of Brugada syndrome. FEBS Letters, 479(1–2), 29–34.
45. Chang, C. C., Acharfi, S., Wu, M. H., Chiang, F. T., Wang, J. K., Sung, T. C., et al. (2004). A novel SCN5A mutation manifests as a malignant form of long QT syndrome with perinatal onset of tachycardia/bradycardia. Cardiovascular Research, 64(2), 268–278.
46. Lupoglazoff, J. M., Cheav, T., Baroudi, G., Berthet, M., Denjoy, I., Cauchemez, B., et al. (2001). Homozygous SCN5A mutation in long-QT syndrome with functional two-to-one atrioventricular block. Circulation Research, 89(2), E16–21.
47. + channel. Circulation, 99(24), 3165–3171.
48. + channel activity through interactions between alpha- and beta1-subunits. Circulation Research, 83(2), 141–146.
49. Veldkamp, M. W., Wilders, R., Baartscheer, A., Zegers, J. G., Bezzina, C. R., & Wilde, A. A. (2003). Contribution of sodium channel mutations to bradycardia and sinus node dysfunction in LQT3 families. Circulation Research, 92(9), 976–983.
50. Bezzina, C., Veldkamp, M. W., van Den Berg, M. P., Postma, A. V., Rook, M. B., Viersma, J. W., et al. (1999). A single Na(+) channel mutation causing both long-QT and Brugada syndromes. Circulation Research, 85(12), 1206–1213.
51. Tan, B. H., Iturralde-Torres, P., Medeiros-Domingo, A., Nava, S., Tester, D. J., Valdivia, C. R., et al. (2007). A novel C-terminal truncation SCN5A mutation from a patient with sick sinus syndrome, conduction disorder and ventricular tachycardia. Cardiovascular Research, 76(3), 409–417.
52. Ziyadeh-Isleem, A., Clatot, J., Duchatelet, S., Gandjbakhch, E., Denjoy, I., Hidden-Lucet, F., et al. (2014). A truncating SCN5A mutation combined with genetic variability causes sick sinus syndrome and early atrial fibrillation. Heart Rhythm, 11(6), 1015–1023.
53. Schott, J. J., Alshinawi, C., Kyndt, F., Probst, V., Hoorntje, T. M., Hulsbeek, M., et al. (1999). Cardiac conduction defects associate with mutations in SCN5A. Nature Genetics, 23(1), 20–21.
54. Probst, V., Kyndt, F., Potet, F., Trochu, J. N., Mialet, G., Demolombe, S., et al. (2003). Haploinsufficiency in combination with aging causes SCN5A-linked hereditary Lenegre disease. Journal of the American College of Cardiology, 41(4), 643–652.
55. + channel mutation leading to loss of function and non-progressive cardiac conduction defects. Journal of Molecular and Cellular Cardiology, 35(5), 549–557.
56. + channelopathies and sinus node dysfunction. Progress in Biophysics and Molecular Biology, 98(2–3), 171–178.
57. + channel (SCN5A) mutations and impaired cardiac pacemaking in sick sinus syndrome. Circulation Research, 107(1), 126–137.
58. + channel. The Journal of Physiology, 498(Pt 3), 641–648.
59. Baruscotti, M., DiFrancesco, D., & Robinson, R. B. (2000). Na(+) current contribution to the diastolic depolarization in newborn rabbit SA node cells. American Journal of Physiology - Heart and Circulatory Physiology, 279(5), H2303–2309.
60. Haufe, V., Cordeiro, J. M., Zimmer, T., Wu, Y. S., Schiccitano, S., Benndorf, K., et al. (2005). Contribution of neuronal sodium channels to the cardiac fast sodium current INa is greater in dog heart Purkinje fibers than in ventricles. Cardiovascular Research, 65(1), 117–127.
61. Du, Y., Huang, X., Wang, T., Han, K., Zhang, J., Xi, Y., et al. (2007). Downregulation of neuronal sodium channel subunits Nav1.1 and Nav1.6 in the sinoatrial node from volume-overloaded heart failure rat. Pflügers Archiv, 454(3), 451–459.
62. Marionneau, C., Couette, B., Liu, J., Li, H., Mangoni, M. E., Nargeot, J., et al. (2005). Specific pattern of ionic channel gene expression associated with pacemaker activity in the mouse heart. The Journal of Physiology, 562(Pt 1), 223–234.
63. Greener, I. D., Monfredi, O., Inada, S., Chandler, N. J., Tellez, J. O., Atkinson, A., et al. (2011). Molecular architecture of the human specialised atrioventricular conduction axis. Journal of Molecular and Cellular Cardiology, 50(4), 642–651.
64. Kalume, F., Westenbroek, R. E., Cheah, C. S., Yu, F. H., Oakley, J. C., Scheuer, T., et al. (2013). Sudden unexpected death in a mouse model of Dravet syndrome. The Journal of Clinical Investigation, 123(4), 1798–1808.
65. Sanders, P., Kistler, P. M., Morton, J. B., Spence, S. J., & Kalman, J. M. (2004). Remodeling of sinus node function in patients with congestive heart failure: reduction in sinus node reserve. Circulation, 110(8), 897–903.
66. Watanabe, H., Koopmann, T. T., Le Scouarnec, S., Yang, T., Ingram, C. R., Schott, J. J., et al. (2008). Sodium channel beta1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. The Journal of Clinical Investigation, 118(6), 2260–2268.
67. Lopez-Santiago, L. F., Meadows, L. S., Ernst, S. J., Chen, C., Malhotra, J. D., McEwen, D. P., et al. (2007). Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals. Journal of Molecular and Cellular Cardiology, 43(5), 636–647.
68. Verkerk, A. O., Wilders, R., van Borren, M. M., Peters, R. J., Broekhuis, E., Lam, K., et al. (2007). Pacemaker current (I(f)) in the human sinoatrial node. European Heart Journal, 28(20), 2472–2478.
69. Milano, A., Vermeer, A. M., Lodder, E. M., Barc, J., Verkerk, A. O., Postma, A. V., et al. (2014). HCN4 mutations in multiple families with bradycardia and left ventricular noncompaction cardiomyopathy. Journal of the American College of Cardiology, 64(8), 745–756.
70. Nof, E., Luria, D., Brass, D., Marek, D., Lahat, H., Reznik-Wolf, H., et al. (2007). Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia. Circulation, 116(5), 463–470.
71. Schweizer, P. A., Schroter, J., Greiner, S., Haas, J., Yampolsky, P., Mereles, D., et al. (2014). The symptom complex of familial sinus node dysfunction and myocardial noncompaction is associated with mutations in the HCN4 channel. Journal of the American College of Cardiology, 64(8), 757–767.
72. Laish-Farkash, A., Glikson, M., Brass, D., Marek-Yagel, D., Pras, E., Dascal, N., et al. (2010). A novel mutation in the HCN4 gene causes symptomatic sinus bradycardia in Moroccan Jews. Journal of Cardiovascular Electrophysiology, 21(12), 1365–1372.
73. Duhme, N., Schweizer, P. A., Thomas, D., Becker, R., Schroter, J., Barends, T. R., et al. (2013). Altered HCN4 channel C-linker interaction is associated with familial tachycardia-bradycardia syndrome and atrial fibrillation. European Heart Journal, 34(35), 2768–2775.
74. Ueda, K., Nakamura, K., Hayashi, T., Inagaki, N., Takahashi, M., Arimura, T., et al. (2004). Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia. The Journal of Biological Chemistry, 279(26), 27194–27198.
75. Schulze-Bahr, E., Neu, A., Friederich, P., Kaupp, U. B., Breithardt, G., Pongs, O., et al. (2003). Pacemaker channel dysfunction in a patient with sinus node disease. The Journal of Clinical Investigation, 111(10), 1537–1545.
76. Milanesi, R., Baruscotti, M., Gnecchi-Ruscone, T., & DiFrancesco, D. (2006). Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel. The New England Journal of Medicine, 354(2), 151–157.
77. Schweizer, P. A., Duhme, N., Thomas, D., Becker, R., Zehelein, J., Draguhn, A., et al. (2010). cAMP sensitivity of HCN pacemaker channels determines basal heart rate but is not critical for autonomic rate control. Circulation. Arrhythmia and Electrophysiology, 3(5), 542–552.
78. Baruscotti, M., Bucchi, A., Viscomi, C., Mandelli, G., Consalez, G., Gnecchi-Rusconi, T., et al. (2011). Deep bradycardia and heart block caused by inducible cardiac-specific knockout of the pacemaker channel gene Hcn4. Proceedings of the National Academy of Sciences of the United States of America, 108(4), 1705–1710.
79. Perez-Lugones, A., McMahon, J. T., Ratliff, N. B., Saliba, W. I., Schweikert, R. A., Marrouche, N. F., et al. (2003). Evidence of specialized conduction cells in human pulmonary veins of patients with atrial fibrillation. Journal of Cardiovascular Electrophysiology, 14(8), 803–809.
80. Suenari, K., Cheng, C. C., Chen, Y. C., Lin, Y. K., Nakano, Y., Kihara, Y., et al. (2012). Effects of ivabradine on the pulmonary vein electrical activity and modulation of pacemaker currents and calcium homeostasis. Journal of Cardiovascular Electrophysiology, 23(2), 200–206.
81. Mangoni, M. E., & Nargeot, J. (2008). Genesis and regulation of the heart automaticity. Physiological Reviews, 88(3), 919–982.
82. 2+ channels in mouse sinoatrial node. The Journal of Physiology, 590(Pt 24), 6327–6342.
83. Mangoni, M. E., Traboulsie, A., Leoni, A. L., Couette, B., Marger, L., Le Quang, K., et al. (2006). Bradycardia and slowing of the atrioventricular conduction in mice lacking CaV3.1/alpha1G T-type calcium channels. Circulation Research, 98(11), 1422–1430.
84. Strandberg, L. S., Cui, X., Rath, A., Liu, J., Silverman, E. D., Liu, X., et al. (2013). Congenital heart block maternal sera autoantibodies target an extracellular epitope on the alpha1G T-type calcium channel in human fetal hearts. PLoS One, 8(9), e72668.
85. Hu, K., Qu, Y., Yue, Y., & Boutjdir, M. (2004). Functional basis of sinus bradycardia in congenital heart block. Circulation Research, 94(4), e32–38.
86. Baig, S. M., Koschak, A., Lieb, A., Gebhart, M., Dafinger, C., Nurnberg, G., et al. (2011). Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness. Nature Neuroscience, 14(1), 77–84.
87. 2+ channels. Cell, 102(1), 89–97.
88. 2+ channels in cardiac pacemaker activity. Proceedings of the National Academy of Sciences of the United States of America, 100(9), 5543–5548.
89. Lahat, H., Eldar, M., Levy-Nissenbaum, E., Bahan, T., Friedman, E., Khoury, A., et al. (2001). Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21. Circulation, 103(23), 2822–2827.
90. Sumitomo, N., Sakurada, H., Taniguchi, K., Matsumura, M., Abe, O., Miyashita, M., et al. (2007). Association of atrial arrhythmia and sinus node dysfunction in patients with catecholaminergic polymorphic ventricular tachycardia. Circulation Journal, 71(10), 1606–1609.
91. 2+ exchanger current disables fight or flight sinoatrial node activity without affecting resting heart rate. Circulation Research, 112(2), 309–317.
92. Groenke, S., Larson, E. D., Alber, S., Zhang, R., Lamp, S. T., Ren, X., et al. (2013). Complete atrial-specific knockout of sodium-calcium exchange eliminates sinoatrial node pacemaker activity. PLoS One, 8(11), e81633.
93. Simrick, S., Schindler, R. F., Poon, K. L., & Brand, T. (2013). Popeye domain-containing proteins and stress-mediated modulation of cardiac pacemaking. Trends in Cardiovascular Medicine, 23(7), 257–263.
94. Froese, A., Breher, S. S., Waldeyer, C., Schindler, R. F., Nikolaev, V. O., Rinne, S., et al. (2012). Popeye domain containing proteins are essential for stress-mediated modulation of cardiac pacemaking in mice. The Journal of Clinical Investigation, 122(3), 1119–1130.
95. Kirchmaier, B. C., Poon, K. L., Schwerte, T., Huisken, J., Winkler, C., Jungblut, B., et al. (2012). The Popeye domain containing 2 (popdc2) gene in zebrafish is required for heart and skeletal muscle development. Developmental Biology, 363(2), 438–450.
96. Szûts, V., Ötvös, F., Dézsi, L., Vágvölgyi, C., Szalontai, B., Dobrzynski, H., et al. (2012). What have we learned from two-pore potassium channels? Their molecular configuration and function in the human heart. Acta Biologica Szegediensis, 56(2), 93–107.
97. Yanni, J., Tellez, J. O., Maczewski, M., Mackiewicz, U., Beresewicz, A., Billeter, R., et al. (2011). Changes in ion channel gene expression underlying heart failure-induced sinoatrial node dysfunction. Circulation. Heart Failure, 4(4), 496–508.
98. Lalevee, N., Monier, B., Senatore, S., Perrin, L., & Semeriva, M. (2006). Control of cardiac rhythm by ORK1, a Drosophila two-pore domain potassium channel. Current Biology, 16(15), 1502–1508.
99. Schindler, R. F., Poon, K. L., Simrick, S., & Brand, T. (2012). The Popeye domain containing genes: essential elements in heart rate control. Cardiovasc Diagn Ther, 2(4), 308–319.
100. Brand, T., Simrick, S. L., Poon, K. L., & Schindler, R. F. (2014). The cAMP-binding Popdc proteins have a redundant function in the heart. Biochemical Society Transactions, 42(2), 295–301.
101. Camozzi, D., Capanni, C., Cenni, V., Mattioli, E., Columbaro, M., Squarzoni, S., et al. (2014). Diverse lamin-dependent mechanisms interact to control chromatin dynamics: focus on laminopathies. Nucleus, 5(5).
102. Mohler, P. J., & Bennett, V. (2005). Ankyrin-based cardiac arrhythmias: a new class of channelopathies due to loss of cellular targeting. Current Opinion in Cardiology, 20(3), 189–193.
103. Robaei, D., Ford, T., & Ooi, S. Y. (2014). Ankyrin-b syndrome: a case of sinus node dysfunction, atrial fibrillation and prolonged QT in a young adult. Heart Lung Circulatory
104. Mohler, P. J., Le Scouarnec, S., Denjoy, I., Lowe, J. S., Guicheney, P., Caron, L., et al. (2007). Defining the cellular phenotype of “ankyrin-B syndrome” variants: human ANK2 variants associated with clinical phenotypes display a spectrum of activities in cardiomyocytes. Circulation, 115(4), 432–441.
105. Ackerman, M. J., & Mohler, P. J. (2010). Defining a new paradigm for human arrhythmia syndromes: phenotypic manifestations of gene mutations in ion channel- and transporter-associated proteins. Circulation Research, 107(4), 457–465.
106. Barbuti, A., Terragni, B., Brioschi, C., & DiFrancesco, D. (2007). Localization of f-channels to caveolae mediates specific beta2-adrenergic receptor modulation of rate in sinoatrial myocytes. Journal of Molecular and Cellular Cardiology, 42(1), 71–78.
107. Vatta, M., Ackerman, M. J., Ye, B., Makielski, J. C., Ughanze, E. E., Taylor, E. W., et al. (2006). Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome. Circulation, 114(20), 2104–2112.
108. Cronk, L. B., Ye, B., Kaku, T., Tester, D. J., Vatta, M., Makielski, J. C., et al. (2007). Novel mechanism for sudden infant death syndrome: persistent late sodium current secondary to mutations in caveolin-3. Heart Rhythm, 4(2), 161–166.
109. Barbuti, A., Scavone, A., Mazzocchi, N., Terragni, B., Baruscotti, M., & Difrancesco, D. (2012). A caveolin-binding domain in the HCN4 channels mediates functional interaction with caveolin proteins. Journal of Molecular and Cellular Cardiology, 53(2), 187–195.
110. Liu, Y., Bai, R., Wang, L., Zhang, C., Zhao, R., Wan, D., et al. (2013). Identification of a novel de novo mutation associated with PRKAG2 cardiac syndrome and early onset of heart failure. PLoS One, 8(5), e64603.